The Akt pathway inhibitors LY294002, wortmannin, and rapamycin, when used in combination with either cisplatin or temozolomide, not only markedly induce apoptosis in metastatic melanoma cell lines but also abrogate the invasiveness of melanoma cells in organotypic cultures [29]. Here, AKT1 is linked to melanoma.